Banner - Home

Potential Savings ON WELCHOL

Restrictions apply

Keep Taking Steps

in the Right Direction

to Help Treat Your

Type 2 Diabetes
and High
Cholesterol

Photos depict models, not actual patients or healthcare professionals.

Diabetes and High Cholesterol

Welchol, along with diet and exercise, is the only FDA-approved medicine with a single active ingredient proven to lower both high blood sugar (A1C) and LDL-C or “bad” cholesterol in adults with type 2 diabetes and high cholesterol.


Benefit 3 block

Benefits of Welchol
Welchol® (colesevelam HCI) lowering LDL-C and A1C Welchol® (colesevelam HCI) lowering LDL-C and A1C

WELCHOL is not for everyone.  Please see Important Safety Information below.

GET INFORMED
Taking Welchol
Welchol® packet  and tablets for oral suspension Welchol® packet  and tablets for oral suspension Phenylketonurics: Welchol for Oral Suspension contains 27 mg phenylalanine per 3.75 gram dose.
Phenylalanine can be harmful to patients with phenylketonuria (PKU).
Learn More

 

Get Welchol Savings, Support, and Rx Reminders

Get Welchol Savings

Print your Welchol Savings Card and start saving today!

Based on a $0 co-pay for a 90-day supply or a $10 co-pay for a 30-day supply.Restrictions apply based on eligibility.

PRINT SAVINGS
CARD NOW

Welchol® coupon for patient savings Welchol® coupon for patient savings

Based on a $0 co-pay for a 90-day supply or a $10 co-pay for a 30-day supply.Restrictions apply based on eligibility.

PRINT SAVINGS
CARD NOW

 

Important Safery Information

What is Welchol (colesevelam HCI)?

Welchol, along with diet and exercise, lowers LDL or “bad” cholesterol.

Welchol lowers LDL cholesterol in boys, and in girls who have had a menstrual period, ages 10 to 17 years, with a condition known as heterozygous familial hypercholesterolemia (a genetic disorder that causes high cholesterol).

Welchol, along with diet and exercise, also lowers blood sugar levels in adult patients with type 2 diabetes mellitus.

Welchol should not be used to treat type 1 diabetes or diabetic ketoacidosis.

Welchol has not been shown to prevent heart disease or heart attacks.

Welchol has not been studied with all anti-diabetes medications.

Welchol has not been studied in all types of hypercholesterolemia.

Welchol has not been studied in children younger than 10 years old or in girls who have not had a menstrual period.

Important Safety Information About Welchol (colesevelam HCI)

Welchol is available by prescription only. Ask your HCP if Welchol is right for you.

Welchol is not for everyone, especially those with:

  • blood triglyceride levels of greater than 500 mg/dL,
  • a history of pancreatitis (inflammation of the pancreas) due to high triglyceride levels, or
  • a history of intestinal blockage.

Tell your health care provider (HCP) if you have high triglycerides (greater than 300 mg/dL). High levels of triglycerides in your blood can cause acute pancreatitis (inflammation of the pancreas). Discontinue Welchol and seek prompt medical attention if the symptoms of acute pancreatitis occur.

Welchol should not be taken if you have stomach or intestinal problems, including gastroparesis (when the stomach takes too long to empty its contents), abnormal contractions of the digestive system, a history of major gastrointestinal tract surgery, if you have trouble swallowing, by those who might be at risk for intestinal blockage, or if you have vitamin A, D, E, or K deficiencies. Tell your HCP if you have any of these conditions.

Cases of intestinal blockage have occurred. Discontinue Welchol and seek medical attention if severe abdominal pain or severe constipation occurs.

Welchol has known interactions with cyclosporine, glimepiride, glipizide, glyburide, levothyroxine, certain birth control pills, olmesartan medoxomil, and metformin extended-release (ER). Welchol has not been studied with all combinations of drugs and supplements. Please tell your HCP about all medications and vitamins/supplements you may be taking before beginning Welchol, as your HCP may tell you to take your other medications and vitamins/supplements 4 hours before taking Welchol.

Remember to tell your HCP if you are pregnant, plan to become pregnant, or are breastfeeding.

Welchol (colesevelam HCl) for Oral Suspension should not be taken in its dry form.

Welchol for Oral Suspension is recommended for, but not limited to, use in appropriate pediatric patients, as well as any patient who has difficulty swallowing.

Phenylketonurics: Welchol for Oral Suspension contains 27 mg phenylalanine per 3.75 gram packet. Phenylalanine can be harmful to patients with phenylketonuria (PKU).

In clinical trials, the adverse reactions observed in ≥2% of patients, and more commonly with Welchol than placebo (“sugar pill”), regardless of investigator assessment of causality seen in:

  • Adult patients with high LDL (“bad” cholesterol) were:
    constipation, indigestion (dyspepsia), nausea, accidental injury, weakness, sore throat, flu-like symptoms, runny nose, and muscle aches
  • Pediatric patients with high LDL (“bad” cholesterol) were:
    inflamed nasal passages and throat, headache, fatigue, creatine phosphokinase (a muscle enzyme) increase, runny nose, and vomiting
  • Adult patients with Type 2 Diabetes were:
    constipation, low blood sugar (hypoglycemia), indigestion (dyspepsia), nausea, high blood pressure (hypertension), and back pain

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see full Prescribing Information for Welchol® (colesevelam HCl).

Savings Card Offer: Eligibility Criteria and Terms & Conditions

To the Patient: You must present this card to the pharmacist along with your WELCHOL® (colesevelam HCl) prescription to participate in the program. For patients with commercial insurance, savings per prescription of WELCHOL will apply after the following out‐of‐pocket expenses are met: $10 per prescription for a 30‐day supply of WELCHOL or $0 per prescription for a 90‐day supply of WELCHOL. Offer may not be combined with any other program offer or discount for WELCHOL. Savings for WELCHOL are subject to a maximum benefit of $150 per 30‐day prescription or $450 per 90‐day prescription. If you have questions regarding your eligibility or benefits, or wish to discontinue participation, call (877) 264‐2440
(8 AM – 8 PM ET, Monday‐Friday)
. When you use this card, you are certifying that you understand the program rules, regulations, and terms and conditions. You are not eligible if you are enrolled in any state or federal health care program, including, but not limited to, Medicare Part D or Medicaid, VA, DOD, or TRICARE/CHAMPUS; or where taxed, restricted, or prohibited by law; or if you do not otherwise comply with the terms of this card. Further, you agree to discontinue using the card if you enroll in any state or federal health care program during the program period. Offer valid in US and Puerto Rico only.

To the Pharmacist: When you use this card, you are certifying that the patient is not enrolled in any federal, state, or other governmental programs for this prescription.

  • Submit transaction to McKesson Corporation, using BIN #610524.
  • If primary coverage exists, input card information as secondary coverage and transmit using the COB segment of NCPDP transaction. Applicable discounts will be displayed in the transaction response.
  • Acceptance of this card is subject to LoyaltyScript® program Terms and Conditions posted at www.mckesson.com/mprstnc.
  • Patient not eligible if enrolled in any state or federal health care program, including, but not limited to, Medicare Part D or Medicaid, VA, DOD, or TRICARE/CHAMPUS, or where taxed, restricted, or prohibited by law. Offer valid in US and Puerto Rico only.
  • The LoyaltyScript® card is not valid for use with any other prescription drug discount or cash cards for WELCHOL. Claims submitted utilizing the program are subject to audit or validation.
  • LoyaltyScript® is not an insurance card.

Daiichi Sankyo, Inc., reserves the right to rescind, revoke, or amend this program, at any time, without notice.

Trademarks not owned by Daiichi Sankyo, Inc., are property of their respective owners.

Move Up Button

Site global Footer